Emails from an executive and sales staff falsely touted an inhaled steroid preparation as a treatment for COVID-19, prompting a warning from the branch of the US Food and Drug Administration (FDA) ...

The US Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) has stepped up its enforcement efforts regarding prescription drug promotion, issuing three new untitled letters ...

The FDA is urging Novo Nordisk to correct what it said were “misleading” claims the drugmaker made in a television advertisement for its new Wegovy pill. The agency sent a letter to Novo Nordisk Feb.

The FDA has scolded Pfizer over Facebook ads for the cancer drug Adcetris, accusing the Big Pharma of failing to adequately communicate the indication, contraindications and risks. Continuing a wave ...

Google is updating its Google Ads Misrepresentation - Misleading Ad Design policy to have stronger and clearer enforcement over ads that use buttons that are deceptive and unclear. Google wrote, "ads ...